PD-0332991, 5-FU, and Oxaliplatin for Advanced Colorectal Cancer

Share this content:

PD-0332991, 5-FU, and Oxaliplatin for Advanced Colorectal Cancer

Sponsor and Collaborators     
Georgetown University
Pfizer

Contact
Ion Cotarla     
202-687-4510     
ic34@georgetown.edu

Rose Hardesty, RN     
202-687-2111     
rk286@georgetown.edu

Julie Kesler, MBA     
(513) 600-6181     
jkesler@exactsciences.com

Investigator    
Michael Pishvaian, MD PhD     
Georgetown University    

ClinicalTrials.gov Identifier
NCT01522989

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs